“…The majority of the studies concerned alcohol use or alcohol disorders (n = 36) (Andres et al ., 2014; Bauer & Ceballos 2014; Betka et al ., 2018; Bladt, 2002; Bruce et al ., 2012; Bujarski et al ., 2010; Bulai & Enea, 2016; Chaudhury et al ., 2006; Craparo, Ardino, Gori & Caretti, 2014; Founta, Adamzik, Tobin, Kirby & Hevey, 2019; Ghorbani, Khosravani, Sharifi Bastan & Jamaati Ardakani, 2017; Greene et al ., 2020; Hahn et al ., 2016; Hasking & Claes, 2020; Honkalampi et al ., 2010; Knapton et al ., 2018, Kopera, Trucco, Jakubczyk et al ., 2018; Loas et al ., 2000; Lyvers et al ., 2012a, 2012b; Lyvers, et al ., 2014a, 2014b, 2014c, 2018a, 2018b, 2019b, 2019c, 2019d; Lyvers, McCann, Coundouris, Edwards & Thorberg, 2018c; Lyvers et al ., 2019c; Maurage, Grynberg, Noel et al ., 2011; Pedersen, Sorensen, Bruun, Christensen & Vedsted, 2016; Shishido et al ., 2013; Speranza et al ., 2004; Zdankiewicz‐Ścigała & Ścigała, 2018; Zdankiewicz‐Ścigała & Ścigała, 2020) or both alcohol and drug use (n = 1) (Speranza et al ., 2004). Seven studies included patients with drug use (heroin) (Craparo et al ., 2016; Meziou et al ., 2019; Parolin et al ., 2017; Bashapoor, Hosseini‐Kiasari, Daneshvar & Kazemi‐Taskooh, 2015), cannabis use (Bulai & Enea, 2016), sedative use (Gilan et al ., 2015) and methamphetamine use (Payer et al ., 2011).…”